Literature DB >> 3875829

Immunopathology of Schistosoma japonicum and S. mansoni infection in B cell depleted mice.

A W Cheever, J E Byram, S Hieny, F von Lichtenberg, M N Lunde, A Sher.   

Abstract

To investigate the role of antibody in the pathogenesis of hepatic granulomas around schistosome eggs, mice were depleted of B cells by treatment from birth with anti-IgM serum and were subsequently infected with Schistosoma japonicum or S. mansoni. Anti-IgM treatment did not affect the development or fecundity of the worms or the larvae within the egg shells. Normal circumoval granulomas were present in the livers of B cell depleted mice 7 or 8 weeks after infection clearly indicating that antibody and immune complexes have no necessary role in the formation of granulomas. Hepatic fibrosis was also similar in B cell depleted and untreated mice at these times. Ten weeks after infection the size of S. japonicum egg granulomas in untreated mice had decreased but no change in the size of granulomas had occurred in B cell depleted mice, and hepatic fibrosis was more marked in treated than in untreated mice. Similar changes were noted in S. mansoni infected mice, assayed at 8 and at 12-13.5 weeks after infection. The effects of B cell depletion in the more chronic infections may be related to the absence of antibody but could also be caused by an influence on B cell-dependent suppressor T cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3875829     DOI: 10.1111/j.1365-3024.1985.tb00086.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  17 in total

1.  Eosinophil chemotactic lymphokine produced by egg-associated granulomas in murine schistosomiasis japonicum.

Authors:  M Owhashi; H Maruyama; Y Nawa
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

Review 2.  Killer B lymphocytes: the evidence and the potential.

Authors:  Steven K Lundy
Journal:  Inflamm Res       Date:  2009-03-05       Impact factor: 4.575

3.  Schistosoma japonicum egg antigen-specific T cell lines in man. Induction of helper and suppressor T cell lines and clones in vitro in a patient with chronic schistosomiasis japonica.

Authors:  N Ohta; T Itagaki; M Minai; K Hirayama; Y Hosaka
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

4.  Dynamic analysis of splenic Th1 and Th2 lymphocyte functions in mice infected with Schistosoma japonicum.

Authors:  Y H Xu; J Macedonia; A Sher; E Pearce; A W Cheever
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

5.  Granulocyte-macrophage colony-stimulating factor enhances the production of eosinophil chemotactic lymphokine by egg-associated granulomas of Schistosoma japonicum-infected mice.

Authors:  M Owhashi; H Maruyama; Y Nawa
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

6.  Fas ligand-expressing B-1a lymphocytes mediate CD4(+)-T-cell apoptosis during schistosomal infection: induction by interleukin 4 (IL-4) and IL-10.

Authors:  Steven K Lundy; Dov L Boros
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

7.  Cytokine control of the granulomatous response in Schistosoma mansoni-infected baboons: role of exposure and treatment.

Authors:  P W Mola; I O Farah; T M Kariuki; M Nyindo; R E Blanton; C L King
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

8.  Soluble egg antigen-stimulated T helper lymphocyte apoptosis and evidence for cell death mediated by FasL(+) T and B cells during murine Schistosoma mansoni infection.

Authors:  S K Lundy; S P Lerman; D L Boros
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

9.  Deficiency of regulatory B cells increases allergic airway inflammation.

Authors:  S K Lundy; A A Berlin; T F Martens; N W Lukacs
Journal:  Inflamm Res       Date:  2005-12       Impact factor: 4.575

10.  Mechanisms of in vivo modulation of granulomatous inflammation in murine schistosomiasis japonicum.

Authors:  G R Olds; A B Stavitsky
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.